Activating the immune system to Pheast on cancer
Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer.
Learn More ScrollOur Leadership

Jacopo Leonardi
Chief Executive Officer, Board Director

Amira Barkal, MD, PhD
Principal Founder, Chief Development Officer, Board Director

Roy Maute, PhD
Cofounder, Chief Scientific Officer

Irving Weissman, MD
Cofounder, Scientific Advisor, Board Director

Ravi Majeti, MD, PhD
Cofounder, Scientific Advisor, and Board Observer

Steve Gillis, PhD
Board Director

R. Jacob Vogelstein, PhD
Board Director
